PDB Short entry for 2OJG HEADER TRANSFERASE 12-JAN-07 2OJG TITLE CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H- TITLE 2 PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK-2, MITOGEN- COMPND 5 ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2, P42-MAPK, ERT1; COMPND 6 EC: 2.7.11.24; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PT7BLUE KEYWDS KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.XIE,M.D.JACOBS REVDAT 4 27-DEC-23 2OJG 1 REMARK SEQADV REVDAT 3 24-FEB-09 2OJG 1 VERSN REVDAT 2 27-MAR-07 2OJG 1 JRNL REVDAT 1 06-FEB-07 2OJG 0 JRNL AUTH A.M.ARONOV,C.BAKER,G.W.BEMIS,J.CAO,G.CHEN,P.J.FORD, JRNL AUTH 2 U.A.GERMANN,J.GREEN,M.R.HALE,M.JACOBS,J.W.JANETKA,F.MALTAIS, JRNL AUTH 3 G.MARTINEZ-BOTELLA,M.N.NAMCHUK,J.STRAUB,Q.TANG,X.XIE JRNL TITL FLIPPED OUT: STRUCTURE-GUIDED DESIGN OF SELECTIVE JRNL TITL 2 PYRAZOLYLPYRROLE ERK INHIBITORS. JRNL REF J.MED.CHEM. V. 50 1280 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17300186 JRNL DOI 10.1021/JM061381F REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 766664.688 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 23756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2164 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2330 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2290 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 9.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2164 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23756 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2841 REMARK 3 BIN R VALUE (WORKING SET) : 0.2440 REMARK 3 BIN FREE R VALUE : 0.3030 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 299 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2756 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 26 REMARK 3 SOLVENT ATOMS : 188 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.73000 REMARK 3 B22 (A**2) : 2.60000 REMARK 3 B33 (A**2) : 3.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.87000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.14 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.590 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.360 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.080 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.020 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 50.40 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : INHIB.PAR REMARK 3 PARAMETER FILE 4 : PARMXRAY.XPL REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OJG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000041211. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23772 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.1 REMARK 200 DATA REDUNDANCY : 2.770 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 14 MG/ML, 20 MM TRIS, PH 7.0, REMARK 280 5 MM DTT, 200 MM NACL. PRECIPITANT: 100 MM HEPES, PH 7.2, 28-30% REMARK 280 PEG-MME-2000, 200 MM AMMONIUM SULFATE, 20 MM 2-ME, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.38800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 GLY A -20 REMARK 465 SER A -19 REMARK 465 SER A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 GLY A -9 REMARK 465 LEU A -8 REMARK 465 VAL A -7 REMARK 465 PRO A -6 REMARK 465 ARG A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 HIS A -2 REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 ALA A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 7 REMARK 465 GLY A 8 REMARK 465 PRO A 9 REMARK 465 GLU A 10 REMARK 465 MET A 11 REMARK 465 VAL A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 GLN A 15 REMARK 465 VAL A 16 REMARK 465 ASP A 330 REMARK 465 MET A 331 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 25 38.98 70.15 REMARK 500 LYS A 46 -5.27 61.23 REMARK 500 SER A 55 74.65 -118.64 REMARK 500 PHE A 57 24.82 -71.48 REMARK 500 ARG A 146 -2.74 79.84 REMARK 500 ASP A 147 42.34 -142.72 REMARK 500 ASP A 165 86.16 64.17 REMARK 500 ASN A 199 16.08 -160.73 REMARK 500 LEU A 292 49.05 -99.10 REMARK 500 ASP A 316 89.18 -159.64 REMARK 500 ASP A 335 51.88 -116.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE A 327 LYS A 328 -131.15 REMARK 500 LYS A 328 PHE A 329 115.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 19A A 360 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OJI RELATED DB: PDB REMARK 900 RELATED ID: 2OJJ RELATED DB: PDB REMARK 900 RELATED ID: 2OK1 RELATED DB: PDB DBREF 2OJG A 0 358 UNP P28482 MK01_HUMAN 1 359 SEQADV 2OJG MET A -21 UNP P28482 CLONING ARTIFACT SEQADV 2OJG GLY A -20 UNP P28482 CLONING ARTIFACT SEQADV 2OJG SER A -19 UNP P28482 CLONING ARTIFACT SEQADV 2OJG SER A -18 UNP P28482 CLONING ARTIFACT SEQADV 2OJG HIS A -17 UNP P28482 EXPRESSION TAG SEQADV 2OJG HIS A -16 UNP P28482 EXPRESSION TAG SEQADV 2OJG HIS A -15 UNP P28482 EXPRESSION TAG SEQADV 2OJG HIS A -14 UNP P28482 EXPRESSION TAG SEQADV 2OJG HIS A -13 UNP P28482 EXPRESSION TAG SEQADV 2OJG HIS A -12 UNP P28482 EXPRESSION TAG SEQADV 2OJG SER A -11 UNP P28482 CLONING ARTIFACT SEQADV 2OJG SER A -10 UNP P28482 CLONING ARTIFACT SEQADV 2OJG GLY A -9 UNP P28482 CLONING ARTIFACT SEQADV 2OJG LEU A -8 UNP P28482 CLONING ARTIFACT SEQADV 2OJG VAL A -7 UNP P28482 CLONING ARTIFACT SEQADV 2OJG PRO A -6 UNP P28482 CLONING ARTIFACT SEQADV 2OJG ARG A -5 UNP P28482 CLONING ARTIFACT SEQADV 2OJG GLY A -4 UNP P28482 CLONING ARTIFACT SEQADV 2OJG SER A -3 UNP P28482 CLONING ARTIFACT SEQADV 2OJG HIS A -2 UNP P28482 CLONING ARTIFACT SEQADV 2OJG MET A -1 UNP P28482 CLONING ARTIFACT SEQRES 1 A 380 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 380 LEU VAL PRO ARG GLY SER HIS MET ALA ALA ALA ALA ALA SEQRES 3 A 380 ALA GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE SEQRES 4 A 380 ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY SEQRES 5 A 380 GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN SEQRES 6 A 380 VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO SEQRES 7 A 380 PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU SEQRES 8 A 380 ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE SEQRES 9 A 380 GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN SEQRES 10 A 380 MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR SEQRES 11 A 380 ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN SEQRES 12 A 380 ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY SEQRES 13 A 380 LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP SEQRES 14 A 380 LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP SEQRES 15 A 380 LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP SEQRES 16 A 380 PRO ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR VAL SEQRES 17 A 380 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 18 A 380 SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL SEQRES 19 A 380 GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE SEQRES 20 A 380 PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE SEQRES 21 A 380 LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN SEQRES 22 A 380 CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER SEQRES 23 A 380 LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE SEQRES 24 A 380 PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS SEQRES 25 A 380 MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU SEQRES 26 A 380 GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP SEQRES 27 A 380 PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE SEQRES 28 A 380 ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS SEQRES 29 A 380 GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY SEQRES 30 A 380 TYR ARG SER HET SO4 A 359 5 HET 19A A 360 21 HETNAM SO4 SULFATE ION HETNAM 19A N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2- HETNAM 2 19A CARBOXAMIDE FORMUL 2 SO4 O4 S 2- FORMUL 3 19A C16 H16 N4 O FORMUL 4 HOH *188(H2 O) HELIX 1 1 HIS A 59 PHE A 76 1 18 HELIX 2 2 LEU A 110 GLN A 117 1 8 HELIX 3 3 SER A 120 ALA A 141 1 22 HELIX 4 4 LYS A 149 SER A 151 5 3 HELIX 5 5 ASP A 173 ASP A 177 5 5 HELIX 6 6 THR A 188 ARG A 192 5 5 HELIX 7 7 ALA A 193 MET A 197 5 5 HELIX 8 8 LYS A 205 ASN A 222 1 18 HELIX 9 9 HIS A 230 GLY A 243 1 14 HELIX 10 10 SER A 246 ILE A 253 1 8 HELIX 11 11 ASN A 255 SER A 264 1 10 HELIX 12 12 PRO A 272 PHE A 277 1 6 HELIX 13 13 ASP A 281 LEU A 292 1 12 HELIX 14 14 GLU A 301 ALA A 307 1 7 HELIX 15 15 HIS A 308 GLU A 312 5 5 HELIX 16 16 ASP A 316 GLU A 320 5 5 HELIX 17 17 GLU A 339 THR A 349 1 11 HELIX 18 18 ALA A 350 GLN A 353 5 4 SHEET 1 A 5 TYR A 23 GLY A 32 0 SHEET 2 A 5 GLY A 35 ASP A 42 -1 O SER A 39 N SER A 27 SHEET 3 A 5 ARG A 48 ILE A 54 -1 O VAL A 49 N ALA A 40 SHEET 4 A 5 VAL A 99 GLN A 103 -1 O VAL A 99 N ILE A 54 SHEET 5 A 5 ILE A 84 ILE A 88 -1 N ASP A 86 O VAL A 102 SHEET 1 B 3 THR A 108 ASP A 109 0 SHEET 2 B 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 B 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 C 2 VAL A 143 LEU A 144 0 SHEET 2 C 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 SITE 1 AC1 4 ARG A 189 ARG A 192 TYR A 231 HOH A 498 SITE 1 AC2 15 ILE A 29 TYR A 34 VAL A 37 ALA A 50 SITE 2 AC2 15 LYS A 52 ILE A 82 GLN A 103 ASP A 104 SITE 3 AC2 15 LEU A 105 MET A 106 ASP A 109 LYS A 112 SITE 4 AC2 15 LEU A 154 ASP A 165 HOH A 387 CRYST1 48.665 70.776 60.141 90.00 109.03 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020549 0.000000 0.007088 0.00000 SCALE2 0.000000 0.014129 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017589 0.00000